CoChat

Safety, Plasma Concentrations, and Efficacy of High-Dose Fluconazole in Invasive Mold Infections

Anaissie, E. J., Kontoyiannis, D. P., Huls, C., Vartivarian, S. E., Karl, C., Prince, R. A., Bosso, J., Bodey, G. P. · 1995 · Journal of Infectious Diseases
Cited by 147

The DOI matches its Crossref record.

Abstract

A trial of the antifungal triazole fluconazole was conducted in cancer patients with presumed or proven mold infection. Groups of patients received fluconazole at four dosages (800, 1200, 1600, or 2000 mg/day). Adverse events, plasma levels, and clinical response were examined. Thirty-nine patients were enrolled. The 28 evaluable patients had presumed (13 patients) or proven (15) mold infection with Aspergillus (4) and Fusarium (3) species, Zygomycetes organisms (1), or nonspeciated mold (7). Adverse effects included elevated liver function test results (8 patients), nausea and vomiting (2), and erythema multiforme (1). Neurologic toxicity occurred in 3 patients receiving 2000 mg/day. Average steady-state peak plasma concentrations were 51.8, 74.4, and 91.8 mg/L for dosages 1200, 1600, and 2000 mg/day, respectively. Seven of 28 evaluable patients responded. Response did not appear to be related to dose. Fluconazole is well tolerated at total daily doses up to 1600 mg. The data suggest a linear plasma concentration-dose relationship. The activity of fluconazole in refractory mold infections seems to be limited.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/172.2.599

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 147

Metadata

Authors
Anaissie, E. J., Kontoyiannis, D. P., Huls, C., Vartivarian, S. E., Karl, C., Prince, R. A., Bosso, J., & Bodey, G. P.
Venue
Journal of Infectious Diseases
Published
1995-08-01
Volume
172
Issue
2
Pages
599-602
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2154671988
Cited by
147
References
0
FWCI
5.46
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Safety, Plasma Concentrations, and Efficacy of High-Dose Fluconazole in Invasive Mold Infections. https://app.cochat.ai/papers/10.1093/infdis/172.2.599
The paper
Anaissie, E. J., Kontoyiannis, D. P., Huls, C., Vartivarian, S. E., Karl, C., Prince, R. A., Bosso, J., & Bodey, G. P. (1995). Safety, Plasma Concentrations, and Efficacy of High-Dose Fluconazole in Invasive Mold Infections. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/172.2.599

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.